![]() |
FDA Commissioner revokes approval of Genentech's Avastin for treatment of mBC
Genentech, a member of the Roche Group, announced today that the FDA Commissioner is revoking the approval of Avastin (bevacizumab) for the treatment of mBC in the United States.
More... |
All times are GMT -7. The time now is 10:34 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021